A Study on the Synthesis and Characterization of hydroxypropyl Cyclodextrin and Cyclodextrininclusion Complexes

The cyclodextrins consist of the 6,7 or the 8 units known as α, β, and Y-CDs, both of which are macro-cyclic oligosaccharides. These units are bound together by -(1,4) (Szejtli, 1988) glucoid bonding, and all glycoside molecules contain C1 (Frömming&Szejtli, 1994). CDs are hydrophilic compounds with a hydrophobic cavity that enables them to create water-based inclusion complexes. Entry into the CD cavity changes the physicochemical characteristics of a compound used. CDs are one of the most significant supramolecular family members used in the food, pharmaceutical and home-grown industries. CDs are naturally occurring compounds which can be developed on a large scale through bacterial fermentation. The other big benefit of CDs is that they are extremely water soluble and humanly untoxic (Hedges, 1988). This section seeks to provide a brief overview of CD physicochemical characteristics, synthesis, complex formation of the inclusion and some of its applications. This dissertation focuses primarily on α CDs and HP α CDs. In 1891 Villiers was isolated from Amylobacter Bacillus cultivation, Cyclodextrins (CDs), which grew from a starch medium. Since Villiers resembled cellulose, the crystalline substance obtained was called cellulosine. Afterwards in 1903, Schardinger isolated the Bacillus macerans, which could be made from cyclodextrins. Since cyclodextrins are characterised as cyclic oligosaccharides by Schardinger, they are called Schardingerdextrins. After Schardinger, Pringsheim pointed out that cyclodextrins have been a complexing factor in cyclodextrin study. The chemical structure of cyclodextrins was clarified at Freudenberg et al. in the mid-30's (1938). In 1950 French and Cramer worked on cyclodextrin

cyclodextrins, had a great influence.

Cyclodextrins is a family consisting of α-(1,4) glucopyranose subunits of cycling oligosaccharides. They are also classified as cycloamylases, cyclomaltoses and dextrins from Schardinger 1. It is formed by intramoleculartransglycosylation by cyclodextrin glucanotransferase (CG Tase) enzyme degradation. The three main CDs are crystalline, homogenous non hygroscopic substances made from glucopyranose units, which have the same torus as Macro-Rings. The α-cyclodextrin consists of six glucopyranose units; the β-cyclodextrin consists of seven, and eight such units.

In cycllodextrins, on the wider edge of the band and the primary hydroxy groups (C6) on the narrow edge, it appears that the Apolar C3 and C5 hydrogeals and the etheral oxygen are within the torus-like molecules, the X-ray structures suggest that they are located at the narrow edge of the ring. This result in a hydrophilic outer molecule dissolving into water and an apolar cavity, which can provide a microheterogeneous environment defined as a hydrophobic matrix. A significant number of crystal structure studies endorse cyclodextrins in solution. Depending on the form of cyclodextrin and guest compound, cyclodextrins crystallise in two primary types of crystal, channel structures and cage structures. These crystal structures show that cyclodextrins in complexes are in the chair with all glucopyranoses in the conformation of the predicted 'round' structure. Moreover, experiments using linear maltohexaoses, which are a parallel double helix, show that α-cyclodextrin is the most tensed form of the steric strain due to cyclization.

Different strategies for dynamic creation of integration complexes have been implemented. The various approaches to the complexation method are representative of the design of the drug molecules, the formulations materials, the process involved and the finished product. Different methods used are discussed below. 1. Physical blending/Milling/Co-grinding/Solid phase complexation: During approximately one hour, two separate molar ratios of 1:1 and 1:2 of the drug and cyclodextrain are blended into morter, with continuous melting. In rapid mass granulators the physical mixtures are often made on a wide scale for 30 minutes. The powdered compounds are stored at temperatures controlled, 25 ± 20 C and humidity controlled conditions. 2. Kneading: Drugs and cyclodextrin are taken in a morter and are carefully combined in various molar ratios with small quantities of water when sludge-like consistency is triturated. The shredding lasts for one hour. The slurry is removed and the air is pulverised and dried at room temperature and passed through sieve No.80 and kept in a dryer.

3. Co-precipitation: In the water or in a short alcohol chain (e.g. ethanol, or isopropanol), cyclodextrin and the active medication are applied to form the satellite solution at 40-60 °C. The complex precipitate, isolated by filtration or centrifugation, is formed after refrigeration. Complexing times will vary between 24 and 48 hours with this approach 4. Neutralization/Precipitation: The active drug is combined with cyclodextrine, and dissolved in alkaline solution. Using hydrochloric acid solution, the resulting transparent solution is then neutralised to the degree of equivalences. A white precipitation is produced at the point of equivalence, which confirms the formation of the inclusion complex. 5. Solvent Evaporation: Cyclodextrin and active medication are separately dissolved into two different miscible solvents and combining the two solutions gives the drug and the complexing agent a molecular dispersion. Finally a stable powdered inclusion compound is vaporised under a vacuum. 6. Spray Drying /Atomisation: At room temperature and solution highly agitated, cyclodextrin is either dissolved or suspended in water (ratio typically 1:10). The medication is gradually applied to the solution or suspension for water cyclodextrin. The active medication may be incorporated or dissolved in a solvent. 7. Freeze-Drying/Lyophilisation: In water and a co-solvent combination, cyclodextrin and active ingredients are dissolved. The complex is insulated in a lyophilizer by freezing the solution. Freeze-drying at 20°C to -60°C is possible. 8. Microwave Irradiation: In a mixture of water and organic solvent, cyclodextrin and an active agent are dissolved. For a short duration of one or two minutes in a microwave oven, the mixture will react at 60°C. After the reaction is finished, the above reaction mixture is added to the residual uncomplexed free medicine and cyclodextrin to properly extract the solvent mix. The resulting precipitation is filtered and secured long enough in a vacuum oven. 9. Supercritical Anti-solvent: Dissolved in a solvent are cyclodextrin and medication. In supercritical conditions, the solution is then fed into a pressure vessel by a screw (i.e. sprayed into supercritical fluid anti-solvent). If the solution is sprayed into a supercritical anti-solvent fluid, the anti-solvent easily spreads into this fluid solvent as the liquid counter spreads into the anti-solvent fluid. The mixture is saturated and the solution is precipitated.

The various factors that influence the formation of cyclodextrin/drug complexes are 1. Types of CD: The forming and efficiency of includes complexes will interfere with the type of CD. Castillo et al. found that the CDs replaced with these have a greater degree of solubility than beta cyclodextrin 30, when they tested their effect on the different CDs, including beta cyclodextrin (β-CD), hydroxypropyl beta cyclodextrin (HP β-CD), methyle beta cyclodextrin (Mβ-CD) in many drugs, such as Albendazole, Mebendazole or Ricobendazole Diaz et al. reported that better stabilisation constant pharmaceutical interest rates were obtained at -CD and HP-CD complexes only31 for the effect of α-CD, -CD, α-CD and HP-CD on Fenuprofen. The efficiency of dissolution of the Ketoprofen was reportedly improved by Mura and his colleagues by Mβ-CD rather than β-CD 32. Nesna et al. found that the CDs viz.-α-CD, β-CD and β-CD alone have an affinity for the binding of CD with Cocaine in water. 2. Cavity Size: The cavity of the α-CD should be modified enough for the drug to fit into the CD. Arias-Blanco and his colleagues have been investigating the cave size of -CD as a compound for gliclazide, whereas that of α-CD as Gliclazide ring34 is not appropriate. The effect of the Ś-CD on digitoxin has been studied by Ueda et al., and it was found that there is a partial improvement in solubility because of the inside of the cavity. In researching the macro-cyclical compounds effects α-CD, β-CD, μ-CD and Ś-CD, Akasaka and his collaborators have shown that relatively stable compounds are achieved by smalling α-CD, CD and larger μ-CD and β-CD36 macrocyclic complexes. The impact of α-CD, -CD and Ţ-CD on ibuprofen has been investigated by Mura et al., which found that improving its dissolution rate with the -Cd, α-CD and α-CD are only very efficient. Lutka and his colleagues have been studying the interaction of γ-CD, HP γ-CD and Dimethyl beta cyclodextricine (DM γ-CD) with prochloro-methazine and have found that the solubility of the drugs has decreased because the promethazine ring is not included in a CD cavity. 3. Effect of Methods of Preparation: Preparation methods have an effect on drug complexation phenomena with CDs. Different techniques such as co-grinding, kneading, solid dispersion, solvent evaporation, co-precipitation, sprinkling or freezing can affect the complexation of drugs and CDs. Complexing performance depends on the characteristics of the drug and CD. Castillo and his colleagues recorded that a freeze-drying method alone is very effective for including complex

CD, M-CD. Ketoprofen studies by Mura et al. with -CD and DM -CD reported stronger dissolution than kneaded precipitation and sealed warming. The Mura et al. researchers have also been able to study the impact of α-CD, β-CD and Ţ-CD on ibuproxam and reported that spray drying and sealed heat treatments for preparation resulted in better complexation for the treatment of α-CD, β-CD and Ţ-CD and kneading have not proved efficient. The most efficient complexation is accomplished by solid dispersion, kneading is ineffective and spray secretion results in a complete complication when the ratio has been set to 1:440. Palmieri et al. have recorded -CD, HP-CD and methoxybutyrate. Moyano et al. experiments on Oxazepam with DMβ-CD showed a stronger dissolution than kneaded studies, spray-drying report. For the integration of sulfamethoxazole complexes with β-CD and HPβ-CD, Pose-Vilarnovo and his colleagues are observing increased dissolution rate via freeze-drying method. Mitrevej et al. tested the effect of β-CD on Glibenclamide and found the product of superior dissolution for grinding, physical mixture and kneading. Studies on tenoxicam β-CD formulation and assessment by Senoferjan and colleagues demonstrated better dissolution efficiency and complex neutralising stability than traditional solvent and kneading methods. 4. pH and Ionisation State: Nagase and his colleagues have studied and documented strong interactions in the acidic region at pH~445 between DY-9760E and the sulfobutyl-ether beta cyclodextrin (SBE—CD). Increased solubility in pH~1 by Jain et al., is achieved for NSC-639829 with SBE—CD. Loftsson et alstudy .'s of various CDs including HP-CD, RM-CD, SBE—CD, Carboxy methyl beta cyclodextrin (CM-CD), and 2-hydroxy3-trimethyl-ammoney beta cyclodextrin (CD) has achieved an improved solubility of ETH-615 with spontaneously mechanised beta cyclodextrin (R M -CD) (HTMA -CD). And with the strongly polar drug in pH~5 the complex stability constants are poor because it is less able to penetrate the cavity for CD, but with the less polar anionic form it was high in pH~1047. In its investigation 48 Dalmoraand his team have demonstrated successful complexation of -CD at low pH.Piroxicam shows this. McCandless et al. find that LevemopamilHCl solubility (mg/mL) is improved 3 times (7.88 to 25.62 at pH ~4) and 325 times more soluble at pH ~10.6)49 (0.0036-1.37. The research by Kim and his fellow students on Ziprasidonemesylate with SBE-CD reported that ion-pair over dissociated ion form50 was more favoured by complexion. Tros de Ilarduya et al. have confirmed that complexation with non-ionized drug 51 is simpler in their studies with Sulindac and CD. Diaz et al. stated that the unionised form was less protected as compared to the ionised form in the 5. Temperature: The effect of SBE-α-CD on DY-9760E and Sulfobutyl-ether-beta cyclodextrin was studied by Nagase with his colleagues and found that temperature change has a marginal effect on the stability constant44. Tros de Ilarduya et al. documented a decrease in Sulindac-α-CD inclusion complex"s apparent stability constant, with an increase in temperature. In their reports by Zarzycki and his co-workers, the association constant showed a reduction in temperature in binding phenolphthalein to α-CD. Jain et al., stated that the stability of the complex decreases constantly and the temperature is increased. 6. Degree of Substitution: The physico-chemical characteristics of CDs can be significantly influenced by the form and number of replacements on the parent CD molecule, including their complexation. A β-CD derivatives, such as HP-β-CD, are not special to the "degree of substitution." The physico-chemical characteristics of samples of the same degree of substitution of HP-β-CD may not be equal to those of the parent CD molecule under different conditions, because of the potential occupation by hydroxypropyl groups in different positions. As the cleanliness of CD can greatly affect the final quality and marketability of the medicine product, the following words used in identification of CD cleanliness must be properly understood.

To describe the development of integration complexes, a broad variety of analytical methods are used. The outcomes of the different methods should be integrated and together for characterisation should be considered. Each approach analyses a specific feature of the inclusion complex. Thus summarising the details given by various means offers a deeper understanding of host-guest experiences and encourages a guest inclusion approach. All the techniques of characterisation are typically focused on the identification of physicochemical properties changes as a result of the formation of an inclusion complex. When assessing the results of the development of an inclusion complex each technique has its own downside. 1 Phase Solubility Diagram: One of the most common strategies used in characterising CD inclusion complexes is the phase solubility diagram. It results in increasing concentrations of CDs from the solubility results of the guest molecule. According to the Higuchi model and Connors56, diagrams can be of form A, where the solubility of the guest molecule increases as a CD concentration increases, where the complex is

gradient. AN (negative), with an initial positive gradient, that, following a certain concentration of CDs, tends to be negative; and AP (positive). The linear increase in solubility in the AL diagrama depends on the CD and a stoichiometry of 1:1 is assumed if the slope is less than or equal to one. Moreover, a direction of greater than one suggests the complex formation of the guest molecule in a higher order. The complexes formed are, after a specific concentration of CD, of greater order than one for the host molecule, when this diagram is AP-type, and AN type diagrams can be clarified by changes in the high concentrations solubilizing agent or by the aggregation of the complexes formed.

The BS (soluble) conformation can occur in Type B diagrams where the complex is limited to solubility. Initially, guest molecules are increasingly condensed and precipitating occurs, lowering the concentration, until the solubility limit is reached. When the complex is insoluble and the initial equilibrium is present, however after some concentration complex precipitation occurs. Type BI charts (insoluble) are obtained. The increase in solubility is linear with the CD concentration increase when the diagram shows confirmation of AL form, in other words the stability constant (Kc) can be calculated using the following equation: Where S0 is the guest molecule's intrinsic solubility. The CD inclusion complexes are evaluated in AL-type diagrams. The value of Kc is determined in such cases to determine the bond force of the host guest

There can be variations between solubility in an acoustic medium and the line interception in y, resulting en different Kc values, for guest molecules with low solubility and AL-type diagrams. Alternatively, it is possible to quantify the value of the complexation efficiency (CE). It just takes into account the pitch value of the linear diagram equation. The guest molecule ratio to CD as well as an increase of the bulk formulation by adding CD can also be calculated by the CE value Increase in formulation bulk = (MWCD/MW Guest molecule) (1+1/CE) The molecular weight of the guest molecule is MWCD where cyclodextrin and MW are the molecular weight. Nevertheless, CE is not the most common form of evaluating drug complexation with CDs. In scientific literature there are many studies using this parameter. In more tests, the Kc value is found, some of which can be found in Table 1.2. The scope of the choice of the researcher for this parameter is indicated. Julian etc. reported AL type phase solubility profile in phase-solubility studies with 5-nitroindazole with DMβ-CD. Aceclofenac with HPβ-CD was also given an AL form profile during the process solubility tests. Also AL form profile was provided by AG11 with HPβ-CD. Most phase solubility research drugs have provided AL profiles with CDs. The phase solubility studies for Efavirenz with β-CD, HPβ-CD and RMβ-CD, have been researched by Sathiagiri et al. and stated that they had phase solubility patterns of the form AL and AP. Also, AL and BS-type phase solubility profiles76 were given by Etodolac and β-CD, HPβ-CD, Ţ-CD. Other CD drugs provided profiles of the AL kind. The phase- solubility profile of α-CD and α-CD for Granisetron was examined by Messner et al. as BS form. BS type profiles on phase solubility

2 Spectroscopic Techniques: NMR spectroscopy is one of the numerous spectroscopic studies to be conducted. It has much broader applications in intra and intermolecular structural clarity and has been commonly used in chemistry. NMR spectroscopy takes the observed variation in chemistry shifts of host and guest protons into account. 3 1H NMR Spectroscopy: Thakkar and Demarco perform spectroscopic CD-complex analysis by observing the shift of the chemical transformation of the H-3 and H-5 protons into the cavity of α-CD, which includes the aromatic ring in the cavity and which is shielded and thus changes chemicals by the anisotropic effect of the aromatic ring. This change in the chemical shift of the hydrogen atoms is due in the phenomenon of inclusion between the host and the guest. 4 13C NMR Spectroscopy: The 13C NMR spectroscopy is an identical approach to the creation of inclusion complexes. This research may be used to better understand the phenomenon of inclusion complexes in aqueous solution. The 13C chemical transformation is mainly due to the cyclodextrin cavity's electric ambient effect and the 13C inclusion transformation can be mainly split into hydrophobic and van der Waals interaction changes. 5 Ultraviolet/Visible Spectroscopy: Inclusion phenomenon is the change in the spectrum of UV-VIS (UV-VIS) absorption in a host molecule. In case of spectral transition, the guest's chromophore is converted to non-polar cyclodextrin from an aqueous medium. These changes must be triggered by disruption of the guest's electronic levels of energy, either by direct contact with the cyclodextrin or by exclusion of water solvation molecules or through a combination of these two effects. In UV spectrum of the included visitors, minor variations are detected, the approach is typically used to detect complexities of the inclusion. For example, in the presence of a hypsochrome or bathochromatic change in absorption ability without changing the Ţmax, evidence of the relationship between cyclodextrin and medication is given. Hydrogen bond is also considered the principal force behind the creation of an inclusion complex and it allows the energy orbit "n" and hypsochrome transition to be reduced (blue shift). Chun et al., reported 1.1 nm of changes in butyrate with (2)6-di-O'Methyl)-βcyclodextrin8 when complexing hydrocortisone. Chun et al. Furthermore, cleavage of the hydrogen bonds occurring in the compound can lead to bathochromical changes due to complexity. Smulevich and his colleagues have examined how the 1,8-dihydroxy anthraquinonecomplexing with μzyclodextrin was 1,2 nm shift. fluorescent guests in solution of CDs. In fact, the addition of a fluorescent guest molecule in the CD cavity usually results in an improvement in fluorescence. The development of integrated complexes usually causes a drug to change excitement and wavelength of emission. Bettinetti et al., and Junquera etc. have stated that fluorescence improvement occurs after complexation of naproxenandbenzocain β-CDs or their hydroxypropylated or methylates derivatives. Fluorescence spectroscopy has been studied for the recognition of naproxen with maltoheptaose and maltohexaose. The results show that both maltoheptaosis and maltohexaose could form 1:1 pseudo-inclusion complexes with the medication as stable as the real α-CD and β-CD inclusion complexes. Moreover, experiments with fluorescence quenching methods on the position of the drug in a complex showing that it has penetrated completely into the CD cavity. 7 Circular Dichroism: Circular dichroism can be an effective method to prove the complexation of the chiral and non-chiral molecules in the integration of the CD and obtain details on the aqueous solution structure of the compound. Both maximums showed a difference in strength and shifting in the presence of naproxen's circular dichroism spectrum; the most intensive effect was observed in the presence of methyl-β-CDs, due to the greater CD interaction with the drug, i.e. the more favourable match between the host and the guest molecules The highest intensity was observed in the presence of the methyl-β-CDs. Changes in circular dichroic spectrum (CD) not only for achiral guest molecules but also for chiral molecules are also seen in the formation of inclusion complexes with cyclodextrin. For example, in spectra of 1 substituted and 2 substituted naphthalene complexes, the cyclodextrin spectrum of β-CD complexes with naphthalene derivates showed a significant variation, suggesting that the substituents' steric impact on the complex formation is such that complexation can vary in mode for these guest molecules. They say that an axial inclusion is indicated by a positive CD band and an equatorial inclusion by a negative CD band. This proposal estimates that 2-substituted naphthalene is axially integrated in the cavity of β-CD. 8 Electron Spin Resonance Spectroscopy: To investigate the phenomenon of inclusion in the aqueous solution, researchers use the electron paramagnetic resonance. In fact, ESR is a useful way to investigate the complexity of inclusion of radicals in aqueous solutions. Given that radicals have a very sensitive hyperfine linkage to the medium polarity its alterations are indicative of the integration complex development as they pass to

between miconazole and cyclodextrines using the freezing drying and kneading process. The physical appearance and size of the formed complexes is completely separate from Miconazole or corresponding cyclodextrines alone in the electron microscopical pictures. Inclusion complexes had a particle size much smaller than cyclodextrins parent. The dimensions were 256.7 and 50 μm respectively of the HPβ-CD and α-cyclodextrin (~CD), with the corresponding complexes of 2,3 and 5 μm respectively. Another example of this was the 1H NMR and ESR titrations to assess the stoichiometry and stability of Α-phenyl-N-ter-butylnitron analogues with methylated β-CDs and their superoxide spine adducts respectively; the ESR titration provided stability constants for the corresponding complexes of cd-nitroxide and suggested bimodal I after superoxide radical spin trap reactions 9 Solubility Studies: In the guest solution solution analysis, for the concentration of cyclodextrin, the formation of the inclusion complex in solution is seen when the guest's solubility increases with cyclodextrin concentration during the complex formation. In complex and uncomplexed forms, vinpocetine aqueous solubility was examined. In order to assess the pH profile and to evaluate the impact of multicomponent complexation on vinpocetine solubility, solubility studies have been conducted. Vinpocetine has been studied and clearly demonstrated the influence of the pH on solubility and dissolution. It was predictable that the degree of vinpocetine dissolution in the gastric environment would be high based on the solubility values obtained, but the pH values generally in the upper regions of the gastrointestinal tract would not satisfy the solubility or dissolution of pure vinpocetine for complete dissolution of the doses. The solution of pure vinpocetine in aqueous solution (in uncomplexed form) was found to be lower than solubility in multi-component vinpocetine (in complexed form).

In this survey, selected drugs and fluorophores with HPα-CD and α-CD were synthesised and characterised. The three anti diabetic medicines that have been selected for the effect of HPα-CD and α-CD investigation include metformin hydrochloride, pioglitazone hydrochloride and glimepiride. The absorbance spectrum and fluorescent spectrum were analysed to display bathochrome shifts, while hypsochrome shifts are observed for pioglitazone hydrochloride both with HPα-CD and with α-CD. This confirms that HPα-CD and α-CD drug integration complexes are formed. The step solubility trials showed AL type profiles that showed that in the case of HPα-CD and α-CD, all three drugs were inclusion complexes with 1:1 stoichiometric ratio. In contrast achieved. Metformin hydrochloride:HPα-CD spectrum revealed an equal magnitude upfield change of H-3 and H-5, suggesting the complete encapsulation of Metformin hydrochloride within the HPα-CD cavity. The magnitude of the H-3 upfield is significantly higher than the H-5, which shows Metformin hydrochloride to encapsulate into the α-CD cavity.

1. Pinho. E, Grootveld. M, Soares, G &Henriques, M 2014, ‗Cyclodextrins as encapsulation agents for plant bioactive compounds‘, Carbohydrate Polymers, vol. 101, pp. 121-135. 2. Villiers, A 1891, ‗Surla fermentation de la féculeparl‘action du ferment butyrique‘, CompteRendu de l Académie de Sciences, vol. 112, pp. 536–538. 3. Eastburn, SD & Tao, BY 1994, ‗Applications of modified cyclodextrins‘, Biotechnology Advances, vol. 12, pp. 325-329. 4. Szetjli, J 1998, ‗Introduction and general overview of cyclodextrin chemistry‘, Chemical Reviews, vol. 98, pp.1743-1753. 5. Thorsteinn, L & Robert, O 2003, ‗Cyclodextrins in solid dosage forms, Drug delivery oral, Business briefing‘, Pharmaceutical Technology, pp.176-180. 6. Loftsson, T & Brewster, ME 1996, ‗Pharmaceutical applications of cyclodextrins .1. Drug solubilization and stabilization‘, Pharmaceutical Journal of Sciences, vol. 85, no.10, pp.1017–1025. 7. Rajewski, RA & Stella, VJ 1996, ‗Pharmaceutical Applications of cyclodextrins, In vivo drug delivery‘, Journal of Pharmaceutical Sciences, vol. 85, no.11, pp.1142-1168. 8. Irie, T &Uekama, K 1997, Pharmaceutical applications of cyclodextrins, Toxicological issues and safety evaluation, Journal of Pharmaceutical Sciences, vol. 86, no. 2, pp.147-162. 9. Hedges, AR 1998, ‗Industrial Applications of Cyclodextrins‘, Chemical Reviews, vol. 98, no. 5, pp. 2035-2044. 10. Lu, XN & Chen, Y 2002, ‗Chiral separation of amino acids derivatized with fluoresceine-5-isothiocyanate by capillary electrophoresis and laser-induced fluorescence detection using mixed selectors of β-cyclodextrin and sodium taurocholate‘, Journal of Chromatography A, vol. 955, no.1, pp.133-140.

Research Scholar, Department of Chemistry, SSSUTMS, Sehore.